Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 9/20 | 0.39 |
| ▸ | ACACB | O00763 | 3/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 2/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19796444 | 0.88 | THRB (0.48) | THRBFFAR1FFAR4 | |
| SCHEMBL19804302 | 0.85 | FFAR1 (0.41) | THRBFFAR1FFAR4APP | |
| SCHEMBL19796432 | 0.85 | THRB (0.48) | THRBFFAR1FFAR4 | |
| SCHEMBL19796440 | 0.83 | THRB (0.49) | THRBFFAR1FFAR4 | |
| SCHEMBL19796374 | 0.82 | THRB (0.50) | THRBFFAR1FFAR4 | |
| SCHEMBL19796368 | 0.80 | S1PR1 (0.39) | THRBFFAR1FFAR4ACACBS1PR1 | |
| SCHEMBL19624624 | 0.78 | FFAR4 (0.40) | THRBFFAR1FFAR4APP | |
| SCHEMBL19804585 | 0.78 | FFAR4 (0.45) | THRBFFAR1FFAR4APPPPARA | |
| SCHEMBL19796452 | 0.78 | THRB (0.51) | THRBFFAR1FFAR4 | |
| SCHEMBL19796905 | 0.77 | FFAR4 (0.38) | THRBFFAR4PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | THRB 4323/4885FFAR1 1057/4885FFAR4 1715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.